chrisvoncsefalvay/vaers-outcomes huggingface dataset:
covid_test_result=Positive; covid_test_result=Positive; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 30-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 24Jun2021 as dose 1, single (Lot number: EW0196), in right arm, on 15Jul2021 as dose 2, single (Lot number: EW0198), in right arm and on 03Mar2022 as dose 3 (booster), single (Lot number: FJ5683) at the age of 29 years, in right arm for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: MURO 128; ELDERBERRY [SAMBUCUS NIGRA]; MAGNESIUM; VITAMIN D [COLECALCIFEROL]; TYLENOL. Past drug history included: Gluten, reaction(s): "Known allergies: Gluten", notes: Known allergies: Gluten; Sulfa-based antibiotics, reaction(s): "known allergies: sulfa-based antibiotics", notes: Known allergies: sulfa-based antibiotics; Ibuprofen, reaction(s): "Known allergies: Ibuprofen", notes: known allergies: ibuprofen. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 05Jul2022, outcome "unknown" and all described as "covid_test_result=Positive". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (23Jun2022) Negative, notes: Nasal Swab; (05Jul2022) Positive, notes: Nasal Swab; (21Oct2021) Negative, notes: BioFire Respiratory 2.1-EZ Panel RT-PCR. Nasal Swab.  Clinical course: It was reported that, got the COVID vaccine shot 1 and shot 2 right before her period was due. Her cramps were so much more horrible than normal. After shot 1, her period cramps caused her to nearly pass out from the severity of the pain. After shot 2, her period cramps caused her to vomit from the severity of the pain. There were no other obvious changes in her meds, work, sicknesses, diet, exercise, stress, etc. that could have affected her cycle. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19.
a fairly significant goose egg red and itchy hot swelling (3") on upper arm at the site of the shingles shot. Also last evening had about 3-4 hours of chills and all over nasty feeling. (1 day post shot). Took Tylenol and went to bed early. Ok in the morning and better this evening. (2 Days after). Swelling not down yet but doesn't feel as bad.
LEFT ARM SWELLING UP INTO SHOULDER AND BACK (SCAPULA AND NECK) WITH REDNESS AND HEAT. TREATED WITH ORAL BENADRYL AND CREAM.
Since getting the vaccine she had a another episode a few days ago of rosacea and her provider prescribed her doxycycline; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ROSACEA (Since getting the vaccine she had a another episode a few days ago of rosacea and her provider prescribed her doxycycline) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Rosacea (took antibiotics).    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ROSACEA (Since getting the vaccine she had a another episode a few days ago of rosacea and her provider prescribed her doxycycline). The patient was treated with DOXYCYCLINE for Rosacea, at an unspecified dose and frequency. At the time of the report, ROSACEA (Since getting the vaccine she had a another episode a few days ago of rosacea and her provider prescribed her doxycycline) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant  medications were reported.
Pt. stated he felt funny, arm tingling & feeling weird face started turning pale after last shot (TYPHOID). Got pt. water then his (L) arm jerked and black-out for 5-10 sec. or less. After woke up in chair (pt. just slouched down when blackout) Ask if if have shortness of breath/rash/swelling - he said no but he did loss/blurred vision before going out called 911 & paramedic came - 4-5 min. later. They (BP, HR  mild diaphoresis progressed to general shaking. Prior to paramedic arrival PT told me he did not eat anything yet & seem anxious when discussing shots said he's not fond of shot. Gave pt. orange juice & 2 reeces pieces & slowly pt improved w/color back on face & vision or this hot/sweaty w arm tingling pt also ate a sandwich & drink gatorade & sat in chair for observation ~ 15 min before ok to walk back to work. F/U w/pt @ 7:15 ON 12/21/09 & pt. said he's fine arm is fine, (no tingling) not sore from shot, which is normal.
This is a 41y.o. female with past medical history significant for past bradycardia, asthma, b12 deficiency, provoked DVT no longer on anticoagulation presents after testing positive for COVID 19 and having symptomatic bradycardia. She tested positive 5 days ago (positive test by PCR in media tab) at an urgent care. She has had both vaccines and a booster one month ago. She states she felt dizzy when she tilts her head back with room spinning sensation and she feels like she's "throwing PAC's" with a tightness in her chest. She has a history of asthma that she states is usually exercised induced and feels like she is wheezing significantly. She admits to shortness of breath, diarrhea, fatigue, decreased appetite. She does not feel dizzy when she stands up or ambulates. She has a significant family history for multiple auto immune disorders however has never been diagnosed with one personally. She does not drink any alcohol or take any over the counter supplements other than a multivitamin, zinc, vit d. She denies significant drug use, marijuana rarely in the edible form. She finds relief with her home albuterol for her shortness of breath and chest tightness. She denies any calf or leg pain. She is a former smoker and quit many years ago. She admits to an 8lb weight gain in the last few days and also admits to taking steroids from urgent care the last 3 days. Denies any swelling in her legs. Denies hearing loss or ringing in the ears.
Initial case was received on 27 October 2009 from a consumer, who is also the patient. A 42-year-old female patient experienced chest pain, shortness of breath, tongue swelling, and felt like her throat was closing after receiving a left deltoid intramuscular injection of Influenza A (H1N1) 2009 Monovalent vaccine - Preservative (lot not reported) on 26 October 2009. The patient had a history of asthma and was allergic to Biaxin, and was taking Albuterol concomitantly. Approximately 15 to 30 minutes post-vaccination, the patient complained of chest pain, shortness of breath, tongue swelling, and felt like her throat was closing. She was treated with Albuterol and Benadryl, and was seen by a physician. At the time of the report on 27 October 2009, all symptoms had resolved except for the tongue swelling. Follow-up information received on 27 October 2009 from a company representative. Number 1-231206115. No other relevant medically significant information was provided. Documents held by sender: None. 11/9/09:  Medical records received from date of service 10/26/09.  Dx: chest tightness. Possible vaccine related adverse event.  Assessment:  Presents 4 hours after receiving H1N1 Flu vaccine with mild throat tightness and chest tightness.  No SOB, no cough.  No swelling of throat.  Pt. to take Zyrtec and seek further attention of sx. worsen.
10/30/15 I was notified by client's interpreter that client was pregnant.  Pregnancy tests on 09.25.15 and 10.09.15 were negative.  Pregnancy test 10.30.15 is positive.
Started with numbness/tingling in face than facial droop noticed in corner of mouth.  by Saturday morning L eye swollen and L corner of mouth with more significant droop.  Hx of Bells palsy from 1st vaccine.
deceased 8-18-22:   positive for covid 8-13-22   , to ER 8-15-22   DNR status,  chest pain, shortness of breath for one day, cough and admitted.  felt to have chf exacerbation;  family member reported he had rec'd monoclonal antibody treatment.  He had been to ER and released 8-13-22 because of no further complaints
Chills, shakes till 3am, body, head,face, teeth, neck, knees, wrist, back, body aches, nausea, palpitations, shortness of breath, vision wavy lines, sinus, burning mouth, face, 5am very hot, residual, headache, face pain, nausea, weakness, some chills, not feeling well.
storage condition; Vaccine administered after being expired; syringe was given chance to warm up a bit while waiting on the patients; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered after being expired), WRONG TECHNIQUE IN DEVICE USAGE PROCESS (syringe was given chance to warm up a bit while waiting on the patients) and PRODUCT STORAGE ERROR (storage condition) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered after being expired) and WRONG TECHNIQUE IN DEVICE USAGE PROCESS (syringe was given chance to warm up a bit while waiting on the patients). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (storage condition). On 06-Aug-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine administered after being expired), WRONG TECHNIQUE IN DEVICE USAGE PROCESS (syringe was given chance to warm up a bit while waiting on the patients) and PRODUCT STORAGE ERROR (storage condition) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   no concomitants were reported no treatment drugs were reported Vaccine was stored in fridge before administration No visual changes of vaccine Maximum temperature was 41 degrees Fahrenheit with average temperature of 39.8 degrees Fahrenheit and minimum: 38.6 degrees Fahrenheit
Fever up to 103F; Coughed up thick mucus which was blood tinged; Seen in ER; 23DEC89 temp down; %JAN90 cough still present; MD did not think cough related to inject;
This is a 59y.o. male with significant past medical history of HTN, T2DM, S/P whipple procedure, dyslipidemia, anxiety, and depression that presented to the hospital with chief complaint of abdominal pain. He reports chronic abdominal pain over the past several years with abrupt worsening yesterday prompting ED evaluation. He admits to RUQ pain that radiates towards the left side of the abdomen. He admits to diffuse abdominal pain and cramping, nausea and vomiting. Denies any fever, chills, chest pain, shortness of breath.    In the ED, patient normotensive, afebrile, stable SPO2 on room air. Coincidental finding of COVID+. CT AP concerning for SBO v ileus. NGT placed. Admitted for further evaluation and management with General surgery consultation.    Patient seen and examined only by the attending physician. NP only responsible for chart review in an effort to limit exposure given the patient's COVID positive status.
Patient received wrong vaccine formulation.  Should have received Moderna 12+ booster dose, but received Moderna Ped 6m-5y half dose in error.
After of the vaccine began feeling generally unwell, had temp and chills. Day after vaccine was same symptoms only worse. 2 days post vaccine was the absolute worst and began having nausea as well. 3 days after vaccine all symptoms except nausea began to improve. Nausea persisted for about 10 weeks. Did go to a telehealth visit in relation to adverse effects of vaccine.
had the shot, still got shingles/ suspected vaccination failure; shingles; so painful; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure, shingles and pain were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.  Additional details were provided as follows: The reporter was the patient. The age at vaccination was not reported. The reporter stated that, had the shot and still got the shingles so painful. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were not provided.
COVID-19 Treatment; COVID-19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 33-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 13Dec2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 33 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Prediabetes" (unspecified if ongoing); "obesity" (unspecified if ongoing). The patient had no known allergies. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jan2023, outcome "unknown" and all described as "COVID-19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Feb2023) Positive. The patient started Paxlovid as treatment from 25Jan2023 to 29Jan2023. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
L hand became blue, felt cold initially then hot, patient then developed L arm spasms and/or chorea.
Low grade fever starting 1/10/2006 for approximately 3-4 days.  Never above 100 degrees.  Rash started late PM 1/10/06-red small bumps on chest, abdomen and back of thighs.  1/12/06 rash more Prednisone as had itching.  Family Dr diagnosed possible varicella.  1/13/06 Kidney specialist diagnosed rash as severe reaction to Hep A vaccine.  Saw child on 1/18/06.  No fever and only a very faint evidence of rash.
Redness, itchting, ver swollen, hot to touch and hard under the skin 8 days after receiving the first dose
Left arm swelling near shoulder. Seen in clinic about 48 hours after Td immunization. Very slightly red, tender, arm sore and unable to elevate well. Temp 101, achy. Placed on Keflex 500mg BID for 10 days. Leaving to go out of town today. Parents to call with update.
1 wk following administration of HD FLUZONE and PREVNAR pt developed sore and redness at site of PREVNAR.
Presented to hospital with increasing SOB, generalized weakness, diarrhea, upper respiratory symptoms. Received Remdesivir. Suffered cardiac arrest with ROSC. TTM. Anoxic brain injury. Family have decided to transition to hospice care with terminal extubation later today.
I was really tired after the vaccine and my arm was sore.  I tested positive with  a home test for COVID-19 on 07/20/2022. I contacted my doctor via Zoom and was prescribed Paxlovid and it really helped.
This spontaneous report was received from a register nurse who stated that on 26-JAN-2015, she inadvertently administered a dose of PNEUMOVAX 23, intramuscular that had expired on 25-JAN-2015 to a patient of unknown age and gender. No adverse events were reported. Additional information has been requested.
Patient got ZOSTAVAX shot on 5/12 and she called on 5/14 that she has 1 x 1 inch swollen red area at injection site. Also, she had headache on 5/12. Her injection site is hot to touch and painful. Pharmacist advised her to contact her Dr. and take BENADRYL.
Developed an Erythematous ,papular,  pruritic rash to bilateral ankles and left knee 2.5 days after receiving 2nd COVID vaccine. Had 1 wheel to left shin.
N/V with severe diarrhea approximately 24 hours after vaccine administration. Symptoms lasted for 36 hours and resolved.
pt came to clinic 6 dasy p/vax & reported approx 30min p/vax was driving in car & broke out in sweat & blacked out;witness stated pt was out x 5min;no hosp visit required;
swollen gland under my arm; This spontaneous case was reported by a physician and describes the occurrence of LYMPHADENOPATHY (swollen gland under my arm) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (swollen gland under my arm). At the time of the report, LYMPHADENOPATHY (swollen gland under my arm) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were reported. No Treatment medications were reported.
Brain fog; Fatigue; Numbness; Tingling in my left arm and left side of my face.; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 30Apr2021 at 11:00(at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 and allergy to penicillins, latex, sulfas, shellfish. Concomitant medications included vitamins nos (MULTIVITAMIN) started on an unknown date for unspecified indication. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 01May2021 at 08:00, two months after the first vaccine, the patient still experience brain fog, fatigue and numbness and tingling in her left arm and left side of her face. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events brain fog, fatigue, numbness and tingling in left arm and left side of face were not recovered at the time of this report.   The lot/batch number for the vaccine (BNT162b2) was not provided and will be requested during follow up.
Myalgia; This case was reported by a other health professional via sales rep and described the occurrence of myalgia in a 18-year-old female patient who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Bexsero. On an unknown date, unknown after receiving Bexsero, the patient experienced myalgia. On an unknown date, the outcome of the myalgia was recovered/resolved.   It was unknown if the reporter considered the myalgia to be related to Bexsero.  Additional case details were reported as follows: The age at vaccination was not reported. The health care professional stated that patient had reported experiencing myalgia which persisted for about a week The reporter consent to follow up.
Patient was seen for symptoms of urinary tract infection possible kidney stone but looks to be quite ill.  3 days later presented in florid heart failure and had a respiratory arrest.  She was intubated.  Echocardiogram showed dilated cardiomyopathy consistent with Takotsubo's cardiomyopathy. She had a heart catheterization which was negative. She was diagnosed with Takotsubo's cardiomyopathy. Extremely complicated course which included intra-aortic balloon pump. Arterial clot around the intra-aortic balloon pump. Emergent embolectomy. Followed by a slow recovery. Patient recovered intact. Patient was anxious about getting a booster for COVID based on the timing of her shot and the severity of her illness. I discussed what happened to her was a rare outcome and could not completely rule out it could be related.  And suggested I would report her case  From discharge summary: history of COPD who was admitted to the hospital on 5/8/2021 with dyspnea.   She had been complaining of this along with a low-grade temp as well as nausea for 1 to 2 days prior to the admission.  She had also been dealing with severe emotional stressors at home prior to the hospitalization which she did not elaborate about.   In the ED she was noted to have atrial fibrillation with RVR and a cardioversion attempt was performed.  This resulted in a brief cardiac arrest and approximately 1 minute of CPR with return of spontaneous circulation.   TTE was performed shortly thereafter and showed a severely hypokinetic left ventricle with findings compatible with Takotsubo cardiomyopathy.  Cardiology was consulted urgently and took the patient to Cath Lab and placed an intra-aortic balloon pump.  Angiogram showed no coronary disease.  It was overall thought that her cardiogenic shock was secondary to Takotsubo cardiomyopathy brought about by severe emotional stressors.   She did require vasopressor support in the ICU and was on balloon pump until 5/12.  She was found to have a pseudoaneurysm of the left groin by CT with active extravasation.  Bleeding resolved; however, on the day the pump was removed there was difficulty finding pulse in the left leg.  Vascular surgery was consulted emergently and she went to the OR which found a left iliofemoral arterial thrombosis with acute limb ischemia and she underwent thrombectomy.
Scabbed over; Broke out in shingles/shingles rash; This is a spontaneous report from a contactable consumer. A 74-year-old female patient received first dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE solution for injection), via an unspecified route of administration, administered in left arm on 26Feb2021 (Batch/Lot Number: EL9267; Expiration Date: May2021) as single dose for COVID-19 immunization. The patient's medical history included low thyroid from an unknown date, diagnosed 20 years ago. There were no concomitant medications. On 08Mar2021, 10 days after the vaccination the patient had broken out in shingles/shingles rash, patient said she had two of her shingles shots three years ago. Patient said she was scheduled for her second dose in 11 days, she enquired that was she eligible to get the second dose of the vaccine as her Shingles rash was scab over. Patient received treatment for shingles, she was prescribes to take Valtrex three times a day for a week, 1gm tablet. The outcome of the event shingles/shingles rash was not recovered, and scab over was unknown.  No follow up attempts are possible. No further information is expected.
On waking 11/8/2021, extreme pain in arms (biceps & other muscles). Daily difficulty turning over & removing blankets; couldn't reach for items. Thighs also very painful, sometimes limping, difficulty walking. on a scale of 1-10 it was 10s over and over.  Saw primary physician12/20/2021. After labwork, treated with prednisone, which is still ongoing. Referral to rheumatologist (appointment at end of April).
Came down with full blown case of flu: cough, headache, chest hurting, ears ringing, dizzy, achy, fever.